Medtronic (MDT)

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQTEM),NYSE:MDTNYSEMDT)(NYSE:SYKNYSESYK,(NASDAQ:PEGANASDAQ) EQNX::TICKER_END

EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQAMZN),NASDAQ:MDAINASDAQMDAI)(NYSE:MDTNYSEMDT EQNX::TICKER_END

Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days

PALM BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - With the advent of Artificial Intelligence (AI), the methods and techniques to diagnose have helped doctors and patients to understand these diseases in a much faster way, leading to the steady employment of AI in multiple diagnoses around the healthcare industry. The field of medical diagnostics is getting revolutionized due to AI. Medical imaging data, including X-rays, MRIs, and ultrasounds are getting analyzed by AI algorithms to help doctors discover and diagnose diseases more accurately and at a much faster rate. This can assist healthcare professionals in making better judgments regarding patient care, leading to increasing AI in diagnostics market size.   A report from Fact.MR projected that revenue from the global Artificial Intelligence in diagnostics market is projected to reach US$ 1.85 billion in 2024 and thereafter increase swiftly at a CAGR of 23.1% to end up at US$ 14.76 billion by 2034.   The report said: “Health issues are rising among people as the world goes through climate change and other environmental factors, people are getting concerned about their health thus leading to more people going to doctors for diagnosis and proper health checkups.   Medical diagnostics is a process through which doctors understand the condition of a patient's body and analyze whether the patient is suffering from any particular harmful disease. The analysis and results of these tests help doctors use the most suitable course of treatment for their patients to fight the diseases, contributing to the overall expansion of the AI in diagnostics market growth.”   Active companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Tempus AI, Inc. (NASDAQTEM), Medtronic plc NYSE: MDTNYSEMDT)(NYSE: SYKNYSESYK, Pegasystems Inc. (NASDAQ: PEGANASDAQ).

EQNX::TICKER_START (NASDAQJFBR),NASDAQ:SERVNASDAQSERV)(NASDAQ:SYMNASDAQSYM,(NASDAQ:MBOTNASDAQ),(NYSE:MDTMDT) EQNX::TICKER_END

PALM BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Innovations in robotics technology, including artificial intelligence, machine learning, and sensor technology, are enhancing the capabilities of medical robots. These advancements enable more precise surgical procedures, improved rehabilitation processes, and efficient hospital logistics, thus attracting more healthcare facilities to adopt robotic solutions. The market is characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to expand the business to cater to the growing demand for medical service robots. A report from Grand View Research said that the global medical service robots market size was estimated at USD 20.59 billion in 2024 and is projected to grow at a CAGR of 16.5% from 2025 to 2030. It said: “The growth can be attributed to the introduction of technologically advanced robotic equipment in the healthcare sector and the rise in per capita healthcare spending. Continuous advancements in technology, such as robotic catheter control systems (CCS), data recorders, data analytics, remote navigation, motion sensors, 3D-Imaging, and HD surgical microscopic cameras, are projected to drive industry growth. Furthermore, the introduction of swarm robotics is opening new opportunities for industry. It is a new approach to coordinating multi-robotic systems through swarm intelligence.” Active Tech Companies in the markets today include Jeffs' Brands Ltd (NASDAQJFBR), Serve Robotics Inc. NASDAQ: SERVNASDAQSERV)(NASDAQ: SYMNASDAQSYM, Microbot Medical Inc. (NASDAQ: MBOTNASDAQ), Medtronic plc (NYSE: MDTMDT).

Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?

EQNX::TICKER_START (OTCQB:AVAI),(NYSETDOC),NASDAQ:TEMNASDAQTEM)(NYSE:MDTNYSEMDT,(NASDAQ:CLOVNASDAQ) EQNX::TICKER_END

Truffles Vein Specialists opens a new clinic at 5041 Dallas Hwy, Powder Springs, delivering expert minimally invasive treatments for varicose veins, spider veins, and other vascular conditions.

Boston Scientific Co (NYSEBSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.

PALM BEACH, Fla. , Nov. 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Healthcare Artificial Intelligence (AI) market exhibits a high degree of innovation, characterized by ongoing advancements in technology. Rapid developments in ML, deep learning, NLP, and computer vision are driving the evolution of AI-powered healthcare solutions. One primary factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes. According to a March 2024 Microsoft-IDC study, 79% of healthcare organizations are presently utilizing AI technology. In addition, the return on investment (ROI) is realized within 14 months, generating USD 3.20 for every USD 1 invested in artificial intelligence (AI). AI technologies hold transformative potential in various areas including medical imaging analysis, predictive analytics, personalized treatment planning, and drug discovery, potentially transforming conventional healthcare practices. A report from Grand View Research said the global AI in healthcare market size, which was estimated at USD 19.27 billion in 2023, is expected to grow at a CAGR of 38.5% from 2024 to 2030. The report said: “Mergers & acquisitions (M&As) play a significant role in shaping the healthcare AI market landscape. Companies [that] engage in M&A activities to expand their AI software and services increase their market reach or acquire specialized technology and expertise. End-users are becoming increasingly aware of the potential benefits of AI in improving patient care, operational efficiency, and healthcare outcomes. Education initiatives and industry events helped raise awareness about the capabilities and applications of AI in healthcare.” A.I. companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Teladoc Health, Inc. (NYSETDOC), Tempus AI, Inc. NASDAQ: TEMNASDAQTEM)(NYSE: MDTNYSEMDT, Clover Health Investments, Corp. (NASDAQ: CLOVNASDAQ).

Markets were mostly positive this week as benign inflation numbers did nothing to dampen expectations that the Federal Reserve will cut interest rates

Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases

The major indexes moved between gains and losses to end the month, but the volatility may ramp back up with the release of the jobs report next Friday

Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.

Surgical robotics company PROCEPT BioRobotics Co. (NASDAQPRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia

NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its second quarter 2024 financial results and provided a business update.

Medical and surgical products manufacturer Stryker Co. (NYSESYK) is a beneficiary of the acute care boom occurring in the healthcare industry.

Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However

Medtronic had another stable quarter with FCF growth and healthy capital returns. Analysts Hold the stock and see it advancing 15% at the midpoint.

MELBOURNE, FL - (NewMediaWire) - May 17, 2024 - WPF Holdings, Inc. (OTC PINK: WPFH) today announced the appointment of Angel Orrantia as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. Mr. Orrantia will assume the responsibility to guide WPFH as it navigates its way to uplist to the Nasdaq or the NYSE. Mr. Orrantia brings a wealth of technology development and management experience, public company experience and technology industry background to his new role with WPFH, a public technology company.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Arecor Therapeutics PLC (AIM:AREC)C CEO Sarah Howell discusses the company's 2023 performance and future plans with Proactive's Stephen Gunnion.

5G technology represents a foundational shift in how we connect and interact with technology, and provides opportunities for potential growth and innovation.

Recent AI innovations have aided and advanced robotics, which is reshaping industries by automating tasks and garnering a surge in global investments.